The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Peapod FOS trial: A phase 2 clinical trial of pembrolizumab in combination with carboplatin and cabazitaxel in aggressive variant metastatic castration-resistant prostate cancer.
 
Jorge Esteban Villarrubia
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Teresa Alonso Gordoa
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen-Cilag; Lilly; MSD Oncology; Pfizer
Research Funding - Ipsen; Janssen Oncology
Travel, Accommodations, Expenses - Janssen Oncology
 
Begoña Mellado-González
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche; Sanofi
Research Funding - Bayer; Janssen; Roche
Travel, Accommodations, Expenses - Janssen; Pfizer
 
Ignacio Duran
Honoraria - Astellas Pharma; AstraZeneca Spain; Bayer/Onyx; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Janssen Oncology; MSD Oncology; Roche/Genentech
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Immunomedics; Janssen Oncology; MSD Oncology; Novartis; Pfizer/EMD Serono; Pharmacyclics; Roche/Genentech; Seagen
Research Funding - Astellas Pharma (Inst); AstraZeneca Spain (Inst); Bayer; Janssen Oncology (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca Spain; Bayer/Onyx; Gilead Sciences; Ipsen; Pfizer/EMD Serono; Roche/Genentech
 
Alvaro Pinto
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen Oncology; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi/Aventis
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Janssen; Pfizer; Roche
 
Alfredo Sanchez
Honoraria - AstraZeneca; Bristol-Myers Squibb/Medarex; Janssen Oncology; MSD Oncology; Novartis; Roche/Genentech; Sanofi
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex; Janssen Oncology; Roche/Genentech; Sanofi
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb/Medarex; Janssen Oncology; MSD Oncology; Novartis; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb/Medarex; Janssen Oncology; pfizer; Roche; Sanofi
 
Albert Font Pous
Consulting or Advisory Role - Astellas Pharma; Janssen; Sanofi
 
Sergio Vazquez-Estevez
Consulting or Advisory Role - AstraZeneca Spain; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; Pfizer; Roche Pharma AG; Sanofi
Speakers' Bureau - AstraZeneca Spain; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Roche
Travel, Accommodations, Expenses - AstraZeneca Spain; Roche Pharma AG
 
Javier Puente
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; MSD Oncology; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen-Cilag; Merck Sharp & Dohme; Pfizer; Roche; Sanofi
Research Funding - Astellas Pharma; Pfizer; Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen-Cilag; MSD Oncology; Pfizer; Roche
 
Enrique Grande
Honoraria - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Dr. Reddy's Laboratories; Eisai; Eusa Pharma; EUSA Pharma; GlaxoSmithKline; IPSEN; Janssen-Cilag; Lilly; Merck KGaA; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; MSD; Pfizer; Roche; Roche
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ipsen (Inst); Lexicon (Inst); Molecular Templates (Inst); Pfizer (Inst); Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Pfizer; Roche/Genentech
 
Miguel Ángel Climent
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai Europe; EUSA Pharma; Ipsen; Janssen; Merck; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Celgene; Eisai; EUSA Pharma; Janssen Oncology; Janssen-Cilag; Merck; MSD Oncology; Pfizer; Roche/Genentech; Sanofi
Travel, Accommodations, Expenses - Bayer; Ipsen; Janssen; Merck; Pfizer; Roche
 
Pablo Maroto-Rey
Consulting or Advisory Role - Astellas Pharma; Bayer; Bayer; BMS; Ipsen; Janssen; Merck/Pfizer
Travel, Accommodations, Expenses - Bayer; Merck/Pfizer
 
Jose Luis Perez-Gracia
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Pierre Fabre; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Roche
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Incyte (Inst); Janssen (Inst); MSD (Inst); Roche (Inst); Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Gilead Sciences; MSD; Roche
 
Santiago Ponce Aix
Consulting or Advisory Role - Bristol-Myers Squibb; Roche
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Daniel Castellano
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sanofi; Sanofi
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Bristol-Myers Squibb; Pfizer; Roche
 
Enrique Gonzalez-Billalabeitia
Consulting or Advisory Role - AstraZeneca; Bayer; Janssen Oncology
Research Funding - Merck
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Bristol-Myers Squibb; Janssen-Cilag; Pfizer; Pfizer; Roche; Sanofi